FDA approves new drug for specific type of advanced breast cancer.
出版信息
Mayo Clin Womens Healthsource. 2007 Oct;11(10):3.
PMID:18418907
Abstract
摘要
相似文献
1
FDA approves new drug for specific type of advanced breast cancer.
Mayo Clin Womens Healthsource. 2007 Oct;11(10):3.
2
Dual-action drug approved for use in advanced breast cancer.
ONS Connect. 2007 Jun;22(6):19.
3
FDA announces fast track approval of new drug for lung cancer.
BMJ. 2003 May 10;326(7397):1004. doi: 10.1136/bmj.326.7397.1004/d.
4
Femara approved as first-line breast cancer therapy.
FDA Consum. 2001 May-Jun;35(3):5.
5
Herceptin : new treatment and new questions.
Tecnologica. 1998 Oct:15-6.
6
Lapatinib and ixabepilone for the treatment of metastatic breast cancer.
Pharmacotherapy. 2008 Oct;28(10):1255-66. doi: 10.1592/phco.28.10.1255.
7
Swimming upstream: an advocate reflects on cancer research and social realities.
J Clin Oncol. 2008 Jun 1;26(16):2783-6. doi: 10.1200/JCO.2008.17.4532.
8
FDA advisors recommend approval of taxol for node-positive breast cancer.
Oncologist. 1999;4(5):430-1.
9
Better prioritization may speed approval of adjuvant therapies in breast cancer.
J Natl Cancer Inst. 2008 Jun 18;100(12):842-4. doi: 10.1093/jnci/djn197. Epub 2008 Jun 10.
10
FDA approves sorafenib for patients with inoperable liver cancer.
Gastroenterology. 2008 Feb;134(2):379. doi: 10.1053/j.gastro.2007.12.037.
Zotero 插件